The COVID-19 pandemic is evolving rapidly, and we would like to assure our customers, partners, and suppliers that we are diligently monitoring the situation and follow the most up-to-date World Health Organization, EU, and local government guidelines.
Our CBO, Dr. Gonçalo Rebelo de Andrade, discusses with Chemicals…
Nanoform and Orion Corporation, a Finnish pharmaceutical company, today announced a collaboration to apply Nanoform’s award-winning CESS® technology to new chemical entities.
Our CCO, Christian Jones, shared his insights with The Medicine…
Nanoform has established Nanoform USA Inc., a wholly owned subsidiary in the US.
Our CCO, Christian Jones, joins The Medicine Maker to discuss…
Nanoform has filed for GMP status with the Finnish Medicines Agency, FIMEA. The drug substance application for GMP clinical manufacture certification exemplifies its progress and growth in the last 12 months.
Our CTO, Niklas Sandler, examines the importance of technological innovation…